Skip to content

Clinical trials

Gastrointestinal Stromal Tumors trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Gastrointestinal Stromal Tumors Country / region: Belgium Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20022
20031
20071
20113
20141
20151
20171
20182
20192
20221
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Active, not recruiting2
Terminated2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Organisation for Research and Treatment of Cancer - EORTC3
Novartis Pharmaceuticals3
Blueprint Medicines Corporation2
Deciphera Pharmaceuticals, LLC2
Pfizer2
Bayer1
Eli Lilly and Company1
GlaxoSmithKline1
IDRX, Inc., a wholly owned subsidiary of GSK, LLC1
Universitaire Ziekenhuizen KU Leuven1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Gastrointestinal Stromal Tumors17
Sarcoma3
Carcinoma, Non-Small-Cell Lung2
Fibrosarcoma2
Gastrointestinal Neoplasms2
Hemangiosarcoma2
Histiocytoma, Malignant Fibrous2
Leiomyosarcoma2
Liposarcoma2
Neoplasm Metastasis2

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.